Advertisement

Dobutamine Injection

[11 July 2014]

Products Affected - Description

Dobutamine injection, Bedford
12.5 mg/mL, 20 mL vial (NDC 55390-0560-90)
 
Dobutamine injection, Hospira
12.5 mg/mL, 20 mL latex-free vial (NDC 00409-2025-20)
500 mg/250 mL premix (NDC 00409-2347-32)
1000 mg/250 mL premix (NDC 00409-3724-32)

Reason for the Shortage

  • Baxter had dobutamine on back order due to increased demand and manufacturing constraints.
  • Ben Venue has stopped production in its plant in Bedford, Ohio and will close in 2014. Ben Venue supplies multiple sterile injectable products for Bedford Laboratories. Supplies of product that has already been manufactured will continue to be released until inventory is depleted. Bedford Laboratories has a small number of products manufactured elsewhere that are not affected by this closure.
  • Hospira has dobutamine on shortage due increased demand for the product.

Available Products

Dobutamine injection, Baxter
250 mg/250 mL premix (NDC 00338-1073-02)
500 mg/250 mL premix (NDC 00338-1075-02)
1000 mg/250 mL premix (NDC 00338-1077-02)
 
Dobutamine injection, Hospira
12.5 mg/mL, 40 mL latex-free vial (NDC 00409-2025-54)
12.5 mg/mL, 20 mL vial, 1 count (NDC 00409-2344-01)
12.5 mg/mL, 20 mL vial, 10 count (NDC 00409-2344-02)
250 mg/250 mL premix (NDC 00409-2346-32)

Estimated Resupply Dates

  • Bedford has dobutamine 12.5 mg/mL 20 mL vials on long-term back order and the company cannot estimate a release date. Ben Venue manufactured dobutamine for Bedford.
  • Hospira has dobutamine 12.5 mg/mL 20 mL latex-free vials on back order and the company estimates a release date of July 2014. Dobutamine 500 mg/250 mL premixes and 1000 mg/250 mL premixes are on back order and the company cannot estimate a release date.

Related Shortages

Updated

July 11, 2014; June 19, 2014; May 19, 2014; April 1, 2014; March 14, 2014; March 13, 2014; March 7, 2014; February 5, 2014; January 29, 2014; January 21, 2014; December 30, 2014; December 18, 2013; November 14, 2013; October 9, 2013; September 30, 2013; September 18, 2013; September 13, 2013; August 14, 2013; August 1, 2013; July 3, 2013; June 28, 2013; June 26, 2013; June 13, 2013; May 14, 2013; May 6, 2013; April 24, 2013; March 26, 2013; March 1, 2013; February 6, 2013; January 23, 2013; January 4, 2013; December 10, 2012; November 28, 2012; October 17, 2012; September 27, 2012; August 2, 2012; July 25, 2012; July 3, 2012; June 27, 2012; June 22, 2012, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement